Prognostic value of alveolar volume in systolic heart failure: A prospective observational study

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Miniati, Massimo ^a   Monti, Simonetta ^b,c   Bottai, Matteo ^d,e   Pavlickova, Ivana ^b   Passino, Claudio ^c,f   Emdin, Michele ^c   Poletti, Roberta ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c CNR   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Alveolar volume; Prognosis; Survival; Systolic heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARBON MONOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ALVEOLAR VOLUME; ARTICLE; CLINICAL TRIAL; COMORBIDITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; LUNG EDEMA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; ORGAN SIZE; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; SPIROMETRY; SURVIVAL TIME; SYSTOLIC HEART FAILURE; THORAX RADIOGRAPHY;

AGED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY ALVEOLI; SPIROMETRY; SURVIVAL RATE;

EID: 84887918338     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-69     Document Type: Article

References (26)

1. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure. A contemporary population-based perspective. Arch Intern Med 2007, 167:490-496. 10.1001/archinte.167.5.490, 17353497.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikovski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen A, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
3. Hosenpud JD, Stibolt TA, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990, 88:493-496. 10.1016/0002-9343(90)90428-G, 2337106.
4. Naum CC, Sciurba FC, Rogers RM. Pulmonary function abnormalities in chronic severe cardiomyopathy preceding heart transplantation. Am Rev Respir Dis 1992, 145:1334-1338. 10.1164/ajrccm/145.6.1334, 1595999.
5. Wasseman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96:2221-2227. 10.1161/01.CIR.96.7.2221, 9337193.
6. Meyer FJ, Borst MM, Zugck C, Kirschke A, Shellenberg D, Kubler W, Haass M. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 2001, 103:2153-2158. 10.1161/01.CIR.103.17.2153, 11331255.
7. Olson TP, Kenneth CB, Johnson BD. Pulmonary function changes associated with cardiomegaly in chronic heart failure. J Card Fail 2007, 13:100-107. 10.1016/j.cardfail.2006.10.018, 1941841, 17395049.
8. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009, 11:130-139. 10.1093/eurjhf/hfn013, 2639415, 19168510.
9. Kannel WB, Hubert H, Lew FA. Vital capacity as a predictor of cardiovascular disease: the Framingham Study. Am Heart J 1983, 105:311-315. 10.1016/0002-8703(83)90532-X, 6823813.
10. Kannel WB, D'Agostino RB, Silbershatz H. Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. Am J Cardiol 1996, 77:1155-1158. 10.1016/S0002-9149(96)00154-3, 8651087.
11. Mascarenhas J, Lourenço P, Lopes R, Azevedo A, Bettencourt P. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. Am Heart J 2008, 155:521-525. 10.1016/j.ahj.2007.10.040, 18294490.
12. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS-Lung Function Study Group The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 2010, 12:685-691. 10.1093/eurjhf/hfq050, 20395261, ECHOS-Lung Function Study Group.
13. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimenoe G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J, Romero M, Tognoni G. Unrecognized ventricular dysfunction in COPD. Eur Respir J 2012, 39:51-58. 10.1183/09031936.00044411, 21700606.
14. Miniati M, Monti S, Bottai M, Passino C, Emdin M, Poletti R. Forced expiratory volume in one second: prognostic value in systolic heart failure. Int J Cardiol 2013, http://dx.doi.org/10.1016/j.ijcard.2013.01.170.
15. Puri S, Baker BL, Oakley CM, Hughes JMB, Cleland JGF. Increased alveolar/capillary membrane resistance in patients with chronic heart failure. Br Heart J 1994, 72:140-144. 10.1136/hrt.72.2.140, 1025477, 7917686.
16. Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G. Alveolar-capillary membrane conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 2002, 23:467-476. 10.1053/euhj.2001.2803, 11863349.
17. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CPM, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735. 10.1183/09031936.05.00034905, 16204605.
18. Roberts CM, MacRae KD, Seed WA. Multibreath and single breath helium dilution lung volumes as a test of airway obstruction. Eur Respir J 1990, 3:515-520.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446. 10.1056/NEJM197112232852601, 5122894.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
21. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968. 10.1183/09031936.05.00035205, 16264058.
22. Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A. Natriuretic peptides (NPs): automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMA for ANP and BNP in heart failure patients and healthy individuals. Clin Chem 2003, 49:1552-1554. 10.1373/49.9.1552, 12928247.
23. Bottai M, Zhang J. Laplace regression with censored data. Biometrical J 2010, 52:487-503.
24. Hernán MA. The hazard of hazard ratios. Epidemiology 2010, 21:13-15. 10.1097/EDE.0b013e3181c1ea43, 3653612, 20010207.
25. Wagenvoort CA, Mooi WJ. Biopsy Pathology of the Pulmonary Vasculature 1989, 170-198. London: Chapman & Hall.
26. Bachofen H, Bachofen M, Weibel ER. Ultrastructural aspects of pulmonary edema. J Thorac Imag 1988, 3:1-7.